- Home
- NRC vs NPCE Comparison
NRC vs NPCE Comparison
Compare NRC & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRC
- NPCE
- Stock Information
- Founded
- NRC 1981
- NPCE 1997
- Country
- NRC United States
- NPCE United States
- Employees
- NRC N/A
- NPCE N/A
- Industry
- NRC Biotechnology: Commercial Physical & Biological Resarch
- NPCE Medical Specialities
- Sector
- NRC Health Care
- NPCE Health Care
- Exchange
- NRC Nasdaq
- NPCE Nasdaq
- Market Cap
- NRC 354.5M
- NPCE 292.9M
- IPO Year
- NRC N/A
- NPCE 2021
- Fundamental
- Price
- NRC $14.65
- NPCE $9.15
- Analyst Decision
- NRC
- NPCE Strong Buy
- Analyst Count
- NRC 0
- NPCE 6
- Target Price
- NRC N/A
- NPCE $16.67
- AVG Volume (30 Days)
- NRC 101.8K
- NPCE 205.3K
- Earning Date
- NRC 10-24-2025
- NPCE 08-12-2025
- Dividend Yield
- NRC 3.27%
- NPCE N/A
- EPS Growth
- NRC N/A
- NPCE N/A
- EPS
- NRC 0.77
- NPCE N/A
- Revenue
- NRC $140,314,000.00
- NPCE $88,570,000.00
- Revenue This Year
- NRC N/A
- NPCE $22.13
- Revenue Next Year
- NRC N/A
- NPCE $6.07
- P/E Ratio
- NRC $19.08
- NPCE N/A
- Revenue Growth
- NRC N/A
- NPCE 23.32
- 52 Week Low
- NRC $9.76
- NPCE $5.45
- 52 Week High
- NRC $22.99
- NPCE $18.98
- Technical
- Relative Strength Index (RSI)
- NRC 47.80
- NPCE 51.74
- Support Level
- NRC $14.45
- NPCE $8.61
- Resistance Level
- NRC $15.60
- NPCE $8.99
- Average True Range (ATR)
- NRC 0.64
- NPCE 0.53
- MACD
- NRC -0.03
- NPCE 0.11
- Stochastic Oscillator
- NRC 17.05
- NPCE 75.00
About NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.